Meitar acted as local counsel for Cisco in its intended acquisition of NDS Group, a leading provider of video software and content security solutions for approximately $5 billion. The transaction is expected to be completed during the second half of 2012.
Meitar represented Objet, an Israel-based manufacturer of 3D printers, in a contemplated IPO on NASDAQ, which in its advanced stages was deferred, in a dual-tracking process, in favor of entering into an all-stock merger of equals with Stratasys, a Delaware corporation (NASDAQ:SSYS). Under this innovative structure, the shares of the publicly traded Stratasys will be exchanged for shares in the currently privately-held Objet. At closing, Objet will simultaneously become the parent company of the merged entities and, for the first time, a publicly traded company on NASDAQ.
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Broadlight a provider of highly integrated networking and fiber access PON (Passive Optical Network) processors in its acquisition by Broadcom Corporation a global leader in semiconductor solutions for wired and wireless communications for approximately $220 million. The transaction was completed on April 5, 2012.
Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of Face.com, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.
Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.
